Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-017134
Filing Date
2022-08-12
Accepted
2022-08-12 16:26:24
Documents
61
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q imgo-20220630.htm   iXBRL 10-Q 2809555
2 EX-10.2 imgo-ex10_2.htm EX-10.2 105699
3 EX-10.3 imgo-ex10_3.htm EX-10.3 56338
4 EX-31.1 imgo-ex31_1.htm EX-31.1 33313
5 EX-31.2 imgo-ex31_2.htm EX-31.2 33151
6 EX-32.1 imgo-ex32_1.htm EX-32.1 22005
7 GRAPHIC img194246786_0.jpg GRAPHIC 87934
  Complete submission text file 0000950170-22-017134.txt   8273721

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imgo-20220630_cal.xml EX-101.CAL 29239
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imgo-20220630_def.xml EX-101.DEF 174585
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imgo-20220630.xsd EX-101.SCH 35899
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imgo-20220630_lab.xml EX-101.LAB 343171
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imgo-20220630_pre.xml EX-101.PRE 256495
55 EXTRACTED XBRL INSTANCE DOCUMENT imgo-20220630_htm.xml XML 1309837
Mailing Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 94080 (415) 529-5055
Imago BioSciences, Inc. (Filer) CIK: 0001623715 (see all company filings)

EIN.: 454915810 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40604 | Film No.: 221160523
SIC: 2834 Pharmaceutical Preparations